Allergan 4Q

4Q Revenues: $1.2 billion (+16%)

4Q Earnings: $221.5 million (+51%)

FY Revenues: $4.5 billion (+2%)

FY Earnings: $621.3 million (+10%)

Comments: Specialty pharmaceuticals sales were up 18% to $995 million in the quarter, and for the year sales were up 5% to $3.7 billion. Eye care pharmaceutical sales increased 21% in the quarter driven by Alphagan and Combigan franchises and Lumigan and Restasis sales.

News from our sister sites